Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...
Patent
1977-07-28
1980-08-19
Myers, Jane S.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant or stably-transformed bacterium encoding one or...
560142, C07C 9326, A61K 31215
Patent
active
042184703
ABSTRACT:
Novel cardiocirculatory analeptics are prepared, which are epinine esters as obtained by reacting epinine (N-methyldopamine) with branched-chain aliphatic carboxylic acids. Exemplary members are 3,4-di-O-butyrylepinine and 3,4-di-O-pivaloylepinine. These medicaments are effective also by the oral route of administration, contrary to the hitherto commonly used dopamine derivatives which are rapidly destroyed by metabolization when administered orally.
REFERENCES:
patent: 2400038 (1946-05-01), Buck
patent: 3809714 (1974-05-01), Hussain et al.
patent: 3868461 (1975-02-01), Hussain et al.
patent: 4031242 (1977-06-01), Jones et al.
Casagrande Cesare
Ferrari Giorgio
Myers Jane S.
Simes Societa Italiana Medicinali e Sintetici S.p.A.
LandOfFree
Epinine esters and pharmaceutical compositions thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Epinine esters and pharmaceutical compositions thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Epinine esters and pharmaceutical compositions thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1427890